| 摘要 |
<p>The present invention belongs to the field of pharmaceutical techniques, and in particular relates to JNK inhibitors as shown by general formulae (I), (1a) or (1b), pharmaceutically acceptable salts or stereoisomers thereof, the preparation method of these compounds, pharmaceutical preparations containing these compounds, and use of these compounds in the preparation of drugs for treating and/or preventing ischemia reperfusion injury, diabetes, neurodegenerative disorders, chronic inflammation, pulmonary fibrosis, liver fibrosis, fatty liver or liver cirrhosis.</p> |
